We offer Illumina microarray processing and expertise accessible to both internal and external researchers. If you would like to discuss your assays or enquire about costs and scheduling, please ...

One such company offering alternatives to conventional microarrays is Illumina of San Diego, California. The company's bead-based technology is available on two distinct substrates, the Sentrix ...

Illumina, Inc. engages in the development ... Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting.

The Leukemia & Lymphoma Society estimates that by year end, 2024 will have seen 187,740 Americans diagnosed with a blood ...

Analysts on Wall Street project that Illumina (ILMN ... Analysts expect 'Revenue- Microarrays- Instruments' to come in at $4.63 million. The estimate suggests a change of -7.4% year over year.

In a report released on December 8, Conor McNamara from RBC Capital maintained a Buy rating on Illumina (ILMN – Research Report), with a price ...

Illumina (ILMN – Research Report) received a Hold rating and price target from Citi analyst Patrick B Donnelly yesterday. The company’s ...